AIDS in Africa
Phase II clinical trials of Kaletra
Extended spectrum of HIV-1 reverse transcriptase mutations in patients receiving multiple nucleoside analog inhibitors
Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy
Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations
Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians
Phenotypic susceptibility and virological outcome in nucleoside-experienced patients receiving three or four antiretroviral drugs
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load
IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART
Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma
Maternal health factors and early pediatric antiretroviral therapy influence the rate of perinatal HIV-1 disease progression in children
Child mortality associated with reasons for non-breastfeeding and weaning
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
From people to places
Rectal use of nonoxynol-9 among men who have sex with men
The relevance of attributable risk measures to HIV prevention planning
T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection
Absolute or total lymphocyte count as a marker for the CD4 T lymphocyte criterion for initiating antiretroviral therapy
Low rate of HIV-1 codon 215 revertants in antiretroviral-experienced patients
Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy
Detection of a new HIV-1 reverse transcriptase mutation (Q145M) conferring resistance to nucleoside and non-nucleoside inhibitors in a patient failing highly active antiretroviral therapy
Hyperlipidemia in HIV-infected patients
HIV seroconversion
Factors associated with the development of diabetes mellitus in HIV-infected patients on antiretroviral therapy
Renal lesions in HIV-1-positive patient treated with tenofovir
Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?
Antiretroviral therapy in the private sector of Nairobi, Kenya
Pneumocystis carinii pneumonia after the discontinuation of long-term antiretroviral therapy in an HIV-1-infected pregnant woman
Balantidium coli in an HIV-infected patient with chronic diarrhoea
Are the recent increases in sexual risk behavior among older or younger men who have sex with men? Answer
Rapid development of central adiposity after postexposure prophylaxis with antiretroviral drugs